atc sales, page-2

  1. 1,604 Posts.
    lightbulb Created with Sketch. 301
    merck 3rd qtr sales of isentress just released yesterday

    ISENTRESS (raltegravir), Merck's first-in-class HIV integrase inhibitor for use in combination with other antiretroviral agents for the treatment of HIV-1 infection, reported worldwide sales of $197 million for the third quarter of 2009, an increase of 84 percent compared with the third quarter 2008.

    so we have for the nrti sales

    ftc 2.4B
    tdf 2.6B
    3tc 1.0B
    atc ???

    and catching up with next year >$1B

    isentress 0.8B
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.